Lice Treatment Market Analysis

The market based on product type is segmented into OTC products and prescription medications. The OTC products segment accounted for majority of market share of 62.6% in 2023.

• OTC lice treatment products offer convenience and accessibility, allowing consumers to purchase them easily from pharmacies, supermarkets, and online retailers. The availability of OTC products without the need for a prescription enables individuals to initiate treatment promptly at the first sign of a lice infestation. Hence, the segment's growth has been impacted by rising environmental concerns along with consumer demand for non-toxic, eco-friendly products, thereby fostering the segment growth.

The lice treatment market based on type is classified into branded and generic. The generic segment dominated the market and is expected to reach USD 1 billion by 2032.

• Generic lice treatment products are typically more affordable than their branded counterparts, making them an attractive option for consumers seeking cost-effective solutions. Also, as healthcare costs continue to rise, affordability becomes a significant consideration for individuals, resulting to increase in product demand, thereby supplementing the market demand.

   

Based on route of administration, the lice treatment market is classified into oral and topical. The topical segment dominated the market and is expected to exhibit 6.3% CAGR between 2024 – 2032.

• Ongoing research and development focused on creating novel formulations for topical lice treatments especially for easier to apply, improved efficacy, and provide longer-lasting effects will spur the market growth.

   

• Also, presence of several companies and their involvement in developing topical lice product that are easy to use and convenient for consumers will further propel the segmental growth.

   

The lice treatment market based on condition is segmented into pediculosis capitis, pediculosis corporis, and pediculosis pubis. The pediculosis capitis segment accounted for market share of 43.7% in 2023.

• Integrated approaches to the management of pediculosis capitis are gaining popularity. These approaches combine various treatment modalities, such as topical treatments, environmental management, and education programs, to achieve better control and prevention of head lice infestations will foster the market growth.

   

• Also, changes in hygiene practices especially while travelling and socioeconomic factors may also influence the prevalence of head lice infestations in certain communities. Thus, availability of different treatment product in the market will augment the market growth.

   

The lice treatment market based on dosage form is segmented into tablets, shampoos, lotions, cream, and other dosage forms. The shampoos segment is expected to reach USD 704.8 million by end of 2032.

• Shampoo formulations are designed to offer convenience and ease of use, particularly for parents treating children with lice infestations. These shampoos are formulated to lather well and rinse out easily, minimizing the time and effort required for treatment. Therefore, manufacturers and healthcare providers are placing greater emphasis on therapeutic education to ensure proper and effective use of lice treatment shampoos. Thus, aforementioned factors associated with shampoo segment will foster the market growth.

   

By distribution channel, the lice treatment market is segmented into hospital pharmacies, retail pharmacies, and other distribution channels. The retail pharmacies is expected to show significant growth of 6.8% during the analysis period.

• One of the major factors contributing to the segmental growth include easy access to a large selection of over-the-counter medical supplies, including a choice of remedies for common ailments.

   

• Also, retail pharmacies are frequently the first choice for worried parents or anyone looking for practical solutions when it comes to treating lice. These pharmacies make it simple for clients to take care of this frequent problem by providing a wide range of lice treatment items, such as multiple shampoos, combs, and treatments. Thus, availability of different treatment products in the retail pharmacies will supplement the market growth.

North America lice treatment market accounted for USD 461.5 million market revenue in 2023 and is anticipated to grow at CAGR of 6.4% between 2024 – 2032 period.

• Presence of a larger infestation pool and an increasing children population are major factors contributing to the growth of the market. Also, manufacturers are expanding their product portfolios to offer a wide range of lice treatment options, including shampoos, lotions, sprays, and kits.

   

• Diverse product offerings cater to different preferences, needs, and age groups, driving market growth and consumer engagement. Thus, aforementioned factors are contributing to the growth of North America market.